[go: up one dir, main page]

ATE237634T1 - Analogen des keratinozytenwachstumfaktors - Google Patents

Analogen des keratinozytenwachstumfaktors

Info

Publication number
ATE237634T1
ATE237634T1 AT95938216T AT95938216T ATE237634T1 AT E237634 T1 ATE237634 T1 AT E237634T1 AT 95938216 T AT95938216 T AT 95938216T AT 95938216 T AT95938216 T AT 95938216T AT E237634 T1 ATE237634 T1 AT E237634T1
Authority
AT
Austria
Prior art keywords
analogue
growth factor
keratinocyte growth
kgf
analogs
Prior art date
Application number
AT95938216T
Other languages
English (en)
Inventor
Bao-Lu Chen
Tsutomu Arakawa
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Application granted granted Critical
Publication of ATE237634T1 publication Critical patent/ATE237634T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Obesity (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Emergency Medicine (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT95938216T 1994-10-13 1995-10-12 Analogen des keratinozytenwachstumfaktors ATE237634T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US32333794A 1994-10-13 1994-10-13
US48782595A 1995-06-07 1995-06-07
PCT/US1995/013075 WO1996011951A2 (en) 1994-10-13 1995-10-12 Keratinocyte growth factor analogs

Publications (1)

Publication Number Publication Date
ATE237634T1 true ATE237634T1 (de) 2003-05-15

Family

ID=26983900

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95938216T ATE237634T1 (de) 1994-10-13 1995-10-12 Analogen des keratinozytenwachstumfaktors

Country Status (14)

Country Link
EP (1) EP0785950B1 (de)
JP (2) JP4422210B2 (de)
AT (1) ATE237634T1 (de)
AU (1) AU3893195A (de)
CA (1) CA2202390C (de)
DE (1) DE69530404T2 (de)
DK (1) DK0785950T3 (de)
ES (1) ES2196088T3 (de)
HU (1) HUT78069A (de)
MX (1) MX9702665A (de)
NO (1) NO971621L (de)
PT (1) PT785950E (de)
SI (1) SI0785950T1 (de)
WO (1) WO1996011951A2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT73453A (en) 1993-06-29 1996-08-28 Chiron Corp A truncated keratinocyte growth factor /kgf/ having increased biological activity
US7084119B2 (en) 1993-06-29 2006-08-01 Chiron Corporation Truncated keratinocyte growth factor (KGF) having increased biological activity
EP1334981B1 (de) * 1994-10-13 2011-01-26 Swedish Orphan Biovitrum AB (publ) Methode zur Reinigung von Keratinozyten-Wachstumfaktoren
US6077692A (en) 1995-02-14 2000-06-20 Human Genome Sciences, Inc. Keratinocyte growth factor-2
US7232667B2 (en) 1995-02-14 2007-06-19 Human Genome Sciences, Inc. Keratinocyte growth factor-2 polynucleotides
US6693077B1 (en) 1995-02-14 2004-02-17 Human Genome Sciences, Inc. Keratinocyte growth factor-2
SK1499A3 (en) 1996-07-19 1999-08-06 Amgen Inc Analogs of cationic proteins
EP1473366A1 (de) * 1996-10-15 2004-11-03 Amgen Inc. Produkte des Keratinocyten-Wachstumsfaktors 2
CA2269077C (en) * 1996-10-15 2004-04-06 Amgen Inc. Keratinocyte growth factor-2 products
US6743422B1 (en) 1996-10-15 2004-06-01 Amgen, Inc. Keratinocyte growth factor-2 products
AU1905799A (en) 1997-12-22 1999-07-12 Human Genome Sciences, Inc. Keratinocyte growth factor-2 formulations
US6869927B1 (en) 1997-12-22 2005-03-22 Human Genome Sciences, Inc. Keratinocyte growth factor-2 formulations
US6248725B1 (en) 1999-02-23 2001-06-19 Amgen, Inc. Combinations and methods for promoting in vivo liver cell proliferation and enhancing in vivo liver-directed gene transduction
JP2005500390A (ja) 2001-08-21 2005-01-06 カイロン コーポレイション Ｋｇｆポリペプチド組成物
ES2504441T3 (es) 2004-12-15 2014-10-08 Swedish Orphan Biovitrum Ab (Publ) Formulaciones terapéuticas del factor de crecimiento de queratinocitos
KR20230127721A (ko) * 2022-02-25 2023-09-01 한국해양과학기술원 온도안정성을 향상시킨 fgf7 폴리펩타이드 및 그 용도

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE197800T1 (de) * 1989-01-31 2000-12-15 Jeffrey S Rubin Dns kodierend für einen für epithelzellen spezifischen wachstumsfaktor
EP0730651B1 (de) * 1993-09-24 2005-07-06 Wyeth Holdings Corporation Strukturelle analoge oberflächenschlaufen der fibroblasten-wachstumsfaktoren

Also Published As

Publication number Publication date
CA2202390A1 (en) 1996-04-25
AU3893195A (en) 1996-05-06
ES2196088T3 (es) 2003-12-16
CA2202390C (en) 2005-05-17
JP2000511762A (ja) 2000-09-12
NO971621D0 (no) 1997-04-09
NO971621L (no) 1997-06-12
WO1996011951A2 (en) 1996-04-25
SI0785950T1 (en) 2003-08-31
HUT78069A (hu) 1999-08-30
DK0785950T3 (da) 2003-07-28
EP0785950A2 (de) 1997-07-30
JP2007020575A (ja) 2007-02-01
DE69530404T2 (de) 2003-11-13
JP4422210B2 (ja) 2010-02-24
EP0785950B1 (de) 2003-04-16
WO1996011951A3 (en) 1996-12-12
PT785950E (pt) 2003-09-30
DE69530404D1 (de) 2003-05-22
MX9702665A (es) 1997-07-31

Similar Documents

Publication Publication Date Title
ATE237634T1 (de) Analogen des keratinozytenwachstumfaktors
ATE81779T1 (de) Peptidanalogedes insulinaehnlichen wachstumsfaktors-1 bei saeugetieren.
BG101408A (bg) Аналози на кератиноцитния растежен фактор
RU94045952A (ru) Домен ингибитора протеазы, днк, вектор, клетка, способ получения ингибитора протеазы, фармацевтическая композиция, применение домена
EP0824545A4 (de) Peptidverbindungen mit wachstumsfaktorähnlicher aktivität
DK0585285T3 (da) Stabiliserede enzymer
NO895028L (no) Ny chimerisk transformerende vekstfaktor-beta.
ATE364079T1 (de) Peptide mit gdp-austauschfaktorartiger wirkung, dafür kodierende nukleinsäuresequenzen, ihre herstellung und verwendung
ES2095255T3 (es) Analogos de sustitucion de peptidos magainina.
ATE242202T1 (de) Peptide
CA2201944A1 (en) Analogs of keratinocyte growth factor having enhanced temperature stability
EP0330700A4 (de) Menschlicher Prourokinase ähnliches Polypeptid.
DK0918795T3 (da) Antiangiogene lægemidler til behandling af cancer, arthritis og retinopati
DE59108261D1 (de) Peptide des HIV-gag Proteins, ihre Herstellung und Verwendung
ATE141947T1 (de) Klonierung eines neuen mitgliedes der familie der fibroblasten-wachstumsfaktoren (fgf)-rezeptoren
ATE178909T1 (de) Inhibitor peptid spezifisch für cathepsin-l
EP1295943A4 (de) Polypeptide mit aktivität der stimulierung von neutrophilen
AU6478194A (en) Ureins derived from alpha,omega-diamino acids and process for their preparation
ATE301199T1 (de) Beta-primeverosidase gen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0785950

Country of ref document: EP

EEIH Change in the person of patent owner